What a great write up Kelly. I’ve shared this with a bunch of folks I know. I’d be curious to hear what your thoughts are around where you think the biggest unmet needs are in the broad market. Efficient computation? Genome analysis for populations? Scalable hardware+software solutions?
I think one other item that hinders growth in the market is access to better user friendly software. Most analysis is done in CLI today and poorly documented. You get PhD students creating software for their thesis, open sourcing it, then no work is done on it for years. Additionally, biologists or drug researchers may not want to learn these software so it slows the adoption of better analysis.
Thanks again for the great read!